You are here

Multiple sclerosis

Rebif Spells Relief

Clinical trials of the multiple sclerosis drug, Rebif, are proving its effectiveness

Cop 1 (Copaxone®): The Story of a Drug

Nearly three decades after a surprising discovery, Copaxone® gets FDA approval for the treatment of MS

Prof. Ruth Arnon
REHOVOT, Israel -- January 28, 1997 -- This week, two scientists from Israel's Weizmann Institute were honored for an...
New Drug for Multiple Sclerosis Receives Recommendation of a U.S. Food And Drug Administration Advisory Committee
REHOVOT, Israel -- September 19, 1996 -- An advisory committee convened by the U.S. Food and Drug Administration...
New Approach to Fighting Autoimmune Diseases
REHOVOT, Israel -- January 25, 1996 -- A natural mechanism by which the body turns off inflammation...
Tuberculosis Bacteria May Protect Against Autoimmune Disease

A protein derived from the tuberculosis bacterium might protect against multiple sclerosis